Efavirenz dosing in patients receiving continuous ambulatory peritoneal dialysis

AIDS. 2000 May 26;14(8):1062-4. doi: 10.1097/00002030-200005260-00021.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Alkynes
  • Anti-HIV Agents / administration & dosage*
  • Anti-HIV Agents / pharmacokinetics
  • Benzoxazines
  • Cyclopropanes
  • HIV Infections / complications
  • HIV Infections / drug therapy*
  • HIV Infections / metabolism
  • Humans
  • Kidney Failure, Chronic / complications*
  • Kidney Failure, Chronic / therapy
  • Male
  • Middle Aged
  • Oxazines / administration & dosage*
  • Oxazines / pharmacokinetics
  • Peritoneal Dialysis, Continuous Ambulatory*
  • Reverse Transcriptase Inhibitors / administration & dosage*
  • Reverse Transcriptase Inhibitors / pharmacokinetics

Substances

  • Alkynes
  • Anti-HIV Agents
  • Benzoxazines
  • Cyclopropanes
  • Oxazines
  • Reverse Transcriptase Inhibitors
  • efavirenz